-
Je něco špatně v tomto záznamu ?
Complement in Kidney Transplantation
Marek Cernoch, Ondrej Viklicky
Jazyk angličtina Země Švýcarsko
Typ dokumentu práce podpořená grantem
Grantová podpora
NV15-26865A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2014
Free Medical Journals
od 2014
PubMed Central
od 2014
Europe PubMed Central
od 2014
Open Access Digital Library
od 2014-01-01
Open Access Digital Library
od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
28611987
DOI
10.3389/fmed.2017.00066
Knihovny.cz E-zdroje
- MeSH
- aktivace komplementu imunologie MeSH
- komplement * imunologie škodlivé účinky MeSH
- lidé MeSH
- pooperační komplikace MeSH
- protilátky imunologie škodlivé účinky MeSH
- rejekce štěpu imunologie MeSH
- reperfuzní poškození imunologie MeSH
- T-lymfocyty imunologie MeSH
- transplantace ledvin * škodlivé účinky MeSH
- transplantáty imunologie MeSH
- trombotické mikroangiopatie imunologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- práce podpořená grantem MeSH
The complement system is considered to be an important part of innate immune system with a significant role in inflammation processes. The activation can occur through classical, alternative, or lectin pathway, resulting in the creation of anaphylatoxins C3a and C5a, possessing a vast spectrum of immune functions, and the assembly of terminal complement cascade, capable of direct cell lysis. The activation processes are tightly regulated; inappropriate activation of the complement cascade plays a significant role in many renal diseases including organ transplantation. Moreover, complement cascade is activated during ischemia/reperfusion injury processes and influences delayed graft function of kidney allografts. Interestingly, complement system has been found to play a role in both acute cellular and antibody-mediated rejections and thrombotic microangiopathy. Therefore, complement system may represent an interesting therapeutical target in kidney transplant pathologies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20016165
- 003
- CZ-PrNML
- 005
- 20240603083830.0
- 007
- ta
- 008
- 201016s2017 sz f 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.3389/fmed.2017.00066 $2 DOI
- 035 __
- $a (Pubmed)28611987
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Černoch, Marek $7 xx0258951 $u Transplant Laboratory, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 245 10
- $a Complement in Kidney Transplantation / $c Marek Cernoch, Ondrej Viklicky
- 520 9_
- $a The complement system is considered to be an important part of innate immune system with a significant role in inflammation processes. The activation can occur through classical, alternative, or lectin pathway, resulting in the creation of anaphylatoxins C3a and C5a, possessing a vast spectrum of immune functions, and the assembly of terminal complement cascade, capable of direct cell lysis. The activation processes are tightly regulated; inappropriate activation of the complement cascade plays a significant role in many renal diseases including organ transplantation. Moreover, complement cascade is activated during ischemia/reperfusion injury processes and influences delayed graft function of kidney allografts. Interestingly, complement system has been found to play a role in both acute cellular and antibody-mediated rejections and thrombotic microangiopathy. Therefore, complement system may represent an interesting therapeutical target in kidney transplant pathologies.
- 650 17
- $a transplantace ledvin $x škodlivé účinky $7 D016030 $2 czmesh
- 650 _7
- $a rejekce štěpu $x imunologie $7 D006084 $2 czmesh
- 650 _7
- $a transplantáty $x imunologie $7 D019737 $2 czmesh
- 650 17
- $a komplement $x imunologie $x škodlivé účinky $7 D003165 $2 czmesh
- 650 _7
- $a aktivace komplementu $x imunologie $7 D003167 $2 czmesh
- 650 _7
- $a pooperační komplikace $7 D011183 $2 czmesh
- 650 _7
- $a reperfuzní poškození $x imunologie $7 D015427 $2 czmesh
- 650 _7
- $a trombotické mikroangiopatie $x imunologie $7 D057049 $2 czmesh
- 650 _7
- $a T-lymfocyty $x imunologie $7 D013601 $2 czmesh
- 650 _7
- $a protilátky $x imunologie $x škodlivé účinky $7 D000906 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 700 1_
- $a Viklický, Ondřej, $d 1966- $7 nlk20050170291 $u Transplant Laboratory, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia ; Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 773 0_
- $t Frontiers in medicine $x 2296-858X $g Roč. 4 (2017), s. 66 $w MED00188756
- 910 __
- $a ABA008 $y 0 $z 0
- 990 __
- $a 20201016160804 $b ABA008
- 991 __
- $a 20240603083829 $b ABA008
- 999 __
- $a kom $b bmc $g 1573221 $s 1106338
- BAS __
- $a 3
- BMC __
- $a 2017 $b 4 $d 66 $x MED00188756 $i 2296-858X $m Frontiers in medicine
- GRA __
- $a NV15-26865A $p MZ0
- LZP __
- $c NLK120 $d 20240603 $a 2020-grant